Maroie Barkati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maroie Barkati has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Bernard Fortin
Centre hospitalier de l'Université de Montréal (CHUM), Department of Radiation Oncology, Montreal, QC, Canada
1 shared publication Danielle Charpentier
1 shared publicationDavid Donath
1 shared publicationDenis Soulières
1 shared publicationF Foroudi
Division of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
1 shared publicationGeneviève Coulombe
1 shared publication
Latest Publications
- 20 April 2010
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 54 (2) , 137-141
The use of magnetic resonance imaging for image‐guided brachytherapy
Progress has been made in the delivery of brachytherapy, from low-dose rate (LDR) to high-dose rate (HDR) treatments, allowing for dose optimisation, conformal treatments, improved radiation protection, and improved accuracy and efficiency. Image-guided brachytherapy, incorporating spatial and temporal changes, is now possible with advanced imaging and treatment technology. This report reviews the evidence for the benefits of image-guided brachytherapy using magnetic resonance imaging (MRI), mainly for cervix and prostate cancer, but also possibilities for other tumour sites. It also emphasises the need for a dedicated MRI unit for brachytherapy.
- 20 April 2010
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 54 (2) , 137-141
The use of magnetic resonance imaging for image‐guided brachytherapy
Progress has been made in the delivery of brachytherapy, from low-dose rate (LDR) to high-dose rate (HDR) treatments, allowing for dose optimisation, conformal treatments, improved radiation protection, and improved accuracy and efficiency. Image-guided brachytherapy, incorporating spatial and temporal changes, is now possible with advanced imaging and treatment technology. This report reviews the evidence for the benefits of image-guided brachytherapy using magnetic resonance imaging (MRI), mainly for cervix and prostate cancer, but also possibilities for other tumour sites. It also emphasises the need for a dedicated MRI unit for brachytherapy.